Susan A. Witham
Plus aucun poste en cours
Profil
Susan A.
Witham held several regulatory affairs positions in the pharmaceutical industry, including Associate Director-Drug Regulatory at Novartis Pharmaceuticals Corp., Director-Regulatory Affairs at Johnson & Johnson Consumer Products Co., Vice President-Regulatory Affairs at Catalent JNP, Inc., Vice President-Regulatory Affairs at Adams Respiratory Therapeutics, Inc., Head-Global Regulatory Affairs at Aventis Pharmaceuticals, Inc., and EVP-Regulatory Affairs & Quality Assurance at Shionogi, Inc. She also served as VP-Regulatory, Quality Assurance & Quality Control at Kremers Urban Pharmaceuticals, Inc. Witham earned an undergraduate degree from Bridgewater College.
Anciens postes connus de Susan A. Witham
| Sociétés | Poste | Fin |
|---|---|---|
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Conseiller Juridique Général | 01/01/2002 |
Johnson & Johnson Consumer Products Co.
 Johnson & Johnson Consumer Products Co. Household/Personal CareConsumer Non-Durables Part of Kenvue, Inc., Johnson & Johnson Consumer Products Co. develops and markets baby care, wound care, and skin care products. Jorge S. Mesquita has been the CEO of the American company since 2014. | Conseiller Juridique Général | - |
Shionogi, Inc.
 Shionogi, Inc. Pharmaceuticals: MajorHealth Technology Part of Shionogi & Co., Ltd., Shionogi, Inc. is a pharmaceutical company based in Florham Park, NJ. Since 1878, the company has been utilizing science to address health challenges and has discovered several novel antibiotics and medications for HIV and influenza. Shionogi conducts ongoing research into established products and new antibiotic compounds, as well as developing an investigational antiviral for COVID-19. The company is committed to pursuing discovery through partnerships, including collaboration with scientists through investigator-initiated research. Shionogi is dedicated to advancing the greater good by developing, partnering, and commercializing medicine to treat serious unmet medical needs in infectious disease and other areas of high medical need including neurology and cardiovascular disease. Nathan McCutcheon has been the CEO of the company since 2019. | Conseiller Juridique Général | - |
Kremers Urban Pharmaceuticals, Inc.
 Kremers Urban Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kremers Urban Pharmaceuticals, Inc. operates as a generic pharmaceutical company. It brands include Aciphex, Colyte, Concerta, Imdur, Lipitor, Monoket and Verelan. The firm provides atorvastatin calcium tablets, hydrocodone polistirex and chlorpheniramine polistirex pennkinetic extended-release tablets. The company was founded in 1904 and is headquartered in Princeton, NJ. | Conseiller Juridique Général | - |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | - |
Formation de Susan A. Witham
| Bridgewater College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Adams Respiratory Therapeutics, Inc.
 Adams Respiratory Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adams Respiratory Therapeutics, Inc. manufactures over-the-counter remedies for respiratory ailments. The company's products include Mucinex, Mucinex DM, Maximum Strength Mucinex, Mucinex DM, Mucinex D, and the Delsym. It is a subsidiary of Reckitt Benckiser Corp. Adams Respiratory Therapeutics is headquartered in Chester, NJ | Health Technology |
Catalent JNP, Inc.
 Catalent JNP, Inc. Pharmaceuticals: MajorHealth Technology Catalent JNP, Inc. engages in the research and development of drugs and therapeutics. It offers analytical characterization and pre-formulation testing; formulation development; and clinical manufacturing of capsules and tablets. The company was founded in December 1986 and is headquartered in Somerset, NJ. | Health Technology |
Aventis Pharmaceuticals, Inc.
Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Kremers Urban Pharmaceuticals, Inc.
Kremers Urban Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kremers Urban Pharmaceuticals, Inc. operates as a generic pharmaceutical company. It brands include Aciphex, Colyte, Concerta, Imdur, Lipitor, Monoket and Verelan. The firm provides atorvastatin calcium tablets, hydrocodone polistirex and chlorpheniramine polistirex pennkinetic extended-release tablets. The company was founded in 1904 and is headquartered in Princeton, NJ. | Health Technology |
Shionogi, Inc.
Shionogi, Inc. Pharmaceuticals: MajorHealth Technology Part of Shionogi & Co., Ltd., Shionogi, Inc. is a pharmaceutical company based in Florham Park, NJ. Since 1878, the company has been utilizing science to address health challenges and has discovered several novel antibiotics and medications for HIV and influenza. Shionogi conducts ongoing research into established products and new antibiotic compounds, as well as developing an investigational antiviral for COVID-19. The company is committed to pursuing discovery through partnerships, including collaboration with scientists through investigator-initiated research. Shionogi is dedicated to advancing the greater good by developing, partnering, and commercializing medicine to treat serious unmet medical needs in infectious disease and other areas of high medical need including neurology and cardiovascular disease. Nathan McCutcheon has been the CEO of the company since 2019. | Health Technology |
Johnson & Johnson Consumer Products Co.
Johnson & Johnson Consumer Products Co. Household/Personal CareConsumer Non-Durables Part of Kenvue, Inc., Johnson & Johnson Consumer Products Co. develops and markets baby care, wound care, and skin care products. Jorge S. Mesquita has been the CEO of the American company since 2014. | Consumer Non-Durables |
